Currenc Group Inc. Files S-1

TL;DR

Currenc Group Inc. (fka InFinT Acquisition Corp) filed its S-1. Public filing details are now available.

AI Summary

Currenc Group Inc. filed an S-1 form on September 30, 2024, detailing its business operations and financial status. The company, formerly known as InFinT Acquisition Corp, is incorporated in E9 and has its fiscal year end on December 31. Its business address is located at 32 Broadway, Suite 401, New York, NY 10004.

Why It Matters

This S-1 filing provides crucial information for investors and the public regarding Currenc Group Inc.'s financial health and business strategy as it potentially prepares for public trading or significant corporate actions.

Risk Assessment

Risk Level: medium — As an S-1 filing, it represents a company in the process of going public or undergoing significant changes, which inherently carries market and operational risks.

Key Numbers

• 1231 — Fiscal Year End (Indicates the end of the company's annual accounting period.)
• 333-282408 — SEC File Number (Unique identifier for the SEC filing.)

Key Players & Entities

• Currenc Group Inc. (company) — Filer of the S-1 document
• InFinT Acquisition Corp (company) — Former name of Currenc Group Inc.
• 32 Broadway, Suite 401, New York, NY 10004 (location) — Business and mailing address
• 20240930 (date) — Filing date of the S-1
• Seamless Group Inc. (company) — Mentioned in relation to related party transactions

FAQ

Key Financial Figures

• $0.0001 — plicable, of ordinary shares, par value $0.0001 per share (the " Ordinary Shares "), of
• $10.00 — of 40,000,000 Ordinary Shares issued at $10.00 per share (the " Exchange Consideration
• $1,944,444 — ote in an aggregate principal amount of $1,944,444, for a purchase price of approximately
• $1.75 million — , for a purchase price of approximately $1.75 million issued in connection with the PIPE Agre
• $11.50 — 6,110 warrants, at an exercise price of $11.50 per share (the " PIPE Warrants ") issue
• $5.7 million — sued promissory notes for approximately $5.7 million to EF Hutton LLC (" EF Hutton "), appro
• $3.2 million — tton LLC (" EF Hutton "), approximately $3.2 million to Greenberg Traurig LLP, and $603,623
• $603,623 — 2 million to Greenberg Traurig LLP, and $603,623 to INFINT Capital LLC (the " Sponsor ")
• $1.94 m — e financings, issuing the PIPE Note for $1.94 million, for a purchase price of approxim
• $1.75 m — , for a purchase price of approximately $1.75 million, 400,000 Commitment Shares, and P
• $1,750,000 — the PIPE Investor at an issue price of $1,750,000, which represents a 10% discount to the
• $2.00 — offerings of Currenc priced at or above $2.00 per share and full anti-dilution protec
• $11 — ares is less than the exercise price of $11.50, subject to adjustment as described
• $2.32 — losing price of our Ordinary Shares was $2.32. We are an "emerging growth company"
• $1.00 — 7,796,842 warrants issued at a price of $1.00 per private warrant to the Sponsor in a

Filing Documents

• forms-1.htm (S-1) — 6239KB
• ex5-1.htm (EX-5.1) — 29KB
• ex23-1.htm (EX-23.1) — 5KB
• ex23-2.htm (EX-23.2) — 4KB
• ex107.htm (EX-FILING FEES) — 48KB
• forms-1_011.jpg (GRAPHIC) — 263KB
• forms-1_002.jpg (GRAPHIC) — 148KB
• forms-1_003.jpg (GRAPHIC) — 212KB
• forms-1_012.jpg (GRAPHIC) — 240KB
• forms-1_005.jpg (GRAPHIC) — 127KB
• forms-1_006.jpg (GRAPHIC) — 53KB
• forms-1_007.jpg (GRAPHIC) — 100KB
• forms-1_008.jpg (GRAPHIC) — 112KB
• forms-1_009.jpg (GRAPHIC) — 53KB
• forms-1_010.jpg (GRAPHIC) — 161KB
• auditorreport_001.jpg (GRAPHIC) — 15KB
• auditorreport_002.jpg (GRAPHIC) — 9KB
• auditorreport_003.jpg (GRAPHIC) — 3KB
• aud_001.jpg (GRAPHIC) — 3KB
• ex23-1_001.jpg (GRAPHIC) — 5KB
• ex23-1_002.jpg (GRAPHIC) — 4KB
• 0001493152-24-038648.txt ( ) — 24279KB
• curr-20240630.xsd (EX-101.SCH) — 102KB
• curr-20240630_cal.xml (EX-101.CAL) — 140KB
• curr-20240630_def.xml (EX-101.DEF) — 805KB
• curr-20240630_lab.xml (EX-101.LAB) — 688KB
• curr-20240630_pre.xml (EX-101.PRE) — 788KB
• forms-1_htm.xml (XML) — 3413KB

USE OF PROCEEDS

USE OF PROCEEDS 42 UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION 43 NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION 50 MARKET INFORMATION FOR COMMON STOCK AND DIVIDEND POLICY 59

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 60 DESCRIPTION OF CURRENC'S BUSINESS 94 DIRECTORS AND EXECUTIVE OFFICERS 133

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 140 PRINCIPAL STOCKHOLDERS 151 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 152

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 160 MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES 165 SELLING SECURITYHOLDERS 168 PLAN OF DISTRIBUTION 170 EXPERTS 171 LEGAL MATTERS 171 WHERE YOU CAN FIND MORE INFORMATION 171 INDEX TO FINANCIAL STATEMENTS F-1 i ABOUT THIS PROSPECTUS The Selling Securityholders may sell up to 40,930,554 Ordinary Shares from time to time in one or more offerings as described in this prospectus, of which (i) 136,110 Ordinary Shares are issuable upon the exercise of the PIPE Warrants, and (ii) 194,444 Ordinary Shares are issuable upon conversion of the PIPE Note. We will not receive any proceeds from the sale of Ordinary Shares by the Selling Securityholders. We may also file a prospectus supplement or post-effective amendment to the registration statement of which this prospectus forms a part that may contain material information relating to these offerings. The prospectus supplement or post-effective amendment, as the case may be, may add, update or change information contained in this prospectus with respect to such offering. If there is any inconsistency between the information in this prospectus and the applicable prospectus supplement or post-effective amendment, you should rely on the prospectus supplement or post-effective amendment, as applicable. Before purchasing any of the Ordinary Shares or Warrants, you should carefully read this prospectus and any prospectus supplement and/or post-effective amendment, as applicable, together with the additional information described under " Where You Can Find More Information ." Neither we nor the Selling Securityholders have authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus and any prospectus supplement and/or post-effective amendment, as applicable, prepared by or on behalf of us or to which we have referred you. We and the Selling Securityholders take no responsibility for, and can provide no a

View Full Filing

View this S-1 filing on SEC EDGAR